These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31087034)

  • 1. Health Care Indicators of Moderate to Severe IBD and Subsequent IBD-Related Disability: A Longitudinal Study.
    Shafer LA; Walker JR; Chhibba T; Targownik LE; Singh H; Ivekovic M; Bernstein CN
    Inflamm Bowel Dis; 2019 Nov; 25(12):1996-2005. PubMed ID: 31087034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent Validation of a Self-Report Version of the IBD Disability Index (IBDDI) in a Population-Based Cohort of IBD Patients.
    Shafer LA; Walker JR; Chhibba T; Ivekovic M; Singh H; Targownik LE; Peyrin-Biroulet L; Gower-Rousseau C; Sarter H; Bernstein CN
    Inflamm Bowel Dis; 2018 Mar; 24(4):766-774. PubMed ID: 29554260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between IBD Disability and Reduced Work Productivity (Presenteeism): A Population-Based Study in Manitoba, Canada.
    Shafer LA; Walker JR; Restall G; Chhibba T; Ivekovic M; Singh H; Targownik LE; Bernstein CN
    Inflamm Bowel Dis; 2019 Jan; 25(2):352-359. PubMed ID: 29992248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease.
    Shafer LA; Shaffer S; Witt J; Nugent Z; Bernstein CN
    Inflamm Bowel Dis; 2022 Aug; 28(8):1189-1197. PubMed ID: 34636400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis.
    Targownik LE; Tennakoon A; Leung S; Lix LM; Singh H; Bernstein CN
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1061-1070.e1. PubMed ID: 28238957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Care Services in IBD: Factors Associated with Service Utilization and Preferences for Service Options for Routine and Urgent Care.
    Bernstein MT; Walker JR; Chhibba T; Ivekovic M; Singh H; Targownik LE; Bernstein CN
    Inflamm Bowel Dis; 2017 Sep; 23(9):1461-1469. PubMed ID: 28816754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI.
    Shafer LA; Sofia MA; Rubin DT; Steinhart AH; Ng SC; Reches L; Israeli E; Bernstein CN
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2524-2531. PubMed ID: 32858200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Academic Performance among Children with Inflammatory Bowel Disease: A Population-Based Study.
    Singh H; Nugent Z; Brownell M; Targownik LE; Roos LL; Bernstein CN
    J Pediatr; 2015 May; 166(5):1128-33. PubMed ID: 25598305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Care Use by a Population-Based Cohort of Children With Inflammatory Bowel Disease.
    Singh H; Nugent Z; Targownik LE; El-Matary W; Brownell M; Bernstein CN
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1302-1309.e3. PubMed ID: 25638585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease.
    Targownik LE; Benchimol EI; Witt J; Bernstein CN; Singh H; Lix L; Tennakoon A; Zubieta AA; Coward S; Jones J; Kuenzig E; Murthy SK; Nguyen GC; Peña-Sánchez JN; Kaplan G
    Inflamm Bowel Dis; 2019 Sep; 25(10):1718-1728. PubMed ID: 31211836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis.
    Targownik LE; Tennakoon A; Leung S; Lix LM; Nugent Z; Singh H; Bernstein CN
    Inflamm Bowel Dis; 2017 Mar; 23(3):409-420. PubMed ID: 28221250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship Between Adverse Childhood Experiences and Health Care Use in the Manitoba IBD Cohort Study.
    Witges KM; Bernstein CN; Sexton KA; Afifi T; Walker JR; Nugent Z; Lix LM
    Inflamm Bowel Dis; 2019 Sep; 25(10):1700-1710. PubMed ID: 30919910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease.
    Long MD; Parlett L; Lewis JD; Haynes K; Adimadhyam S; Hou L; Wolfe A; Toh S; Burris J; Dorand J; Kappelman MD
    Inflamm Bowel Dis; 2024 Aug; 30(8):1345-1352. PubMed ID: 37611117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability Index.
    Lauriot Dit Prevost C; Azahaf M; Nachury M; Branche J; Gerard R; Wils P; Lambin T; Desreumaux P; Ernst O; Pariente B
    Aliment Pharmacol Ther; 2020 May; 51(9):889-898. PubMed ID: 32221985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions.
    van der Have M; Fidder HH; Leenders M; Kaptein AA; van der Valk ME; van Bodegraven AA; Dijkstra G; de Jong DJ; Pierik M; Ponsioen CY; van der Meulen-de Jong AE; van der Woude CJ; van de Meeberg PC; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; Bolwerk CJ; Vermeijden JR; Siersema PD; Oldenburg B; ;
    Inflamm Bowel Dis; 2015 Feb; 21(2):369-77. PubMed ID: 25569738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care utilization in elderly onset inflammatory bowel disease: a population-based study.
    Nguyen GC; Sheng L; Benchimol EI
    Inflamm Bowel Dis; 2015 Apr; 21(4):777-82. PubMed ID: 25738376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study.
    Nugent Z; Singh H; Targownik LE; Strome T; Snider C; Bernstein CN
    Inflamm Bowel Dis; 2016 Dec; 22(12):2907-2916. PubMed ID: 27846193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating a Measure of Patient Self-efficacy in Disease Self-management Using a Population-based IBD Cohort: The IBD Self-efficacy Scale.
    Graff LA; Sexton KA; Walker JR; Clara I; Targownik LE; Bernstein CN
    Inflamm Bowel Dis; 2016 Sep; 22(9):2165-72. PubMed ID: 27542132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
    Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
    Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.